GCP
BIIB icon

Garda Capital Partners’s Biogen BIIB Stock Holding History

Garda Capital Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,000
Closed -$431K – 455
2024
Q1 		$431K Sell
2,000
-800
-29% -$187K 0.02% 343
2023
Q4 		$725K Hold
2,800
– – 0.06% 288
2023
Q3 		$720K Buy
+2,800
New +$749K 0.03% 457

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Garda Capital Partners's BIIB Position: Q2 2024 in Review

Garda Capital Partners sold out of Biogen (BIIB) in Q2 2024, closing a stake of 1,579 shares — an estimated $340K sold.

Garda Capital Partners first reported a position in BIIB in Q1 2023 and held it in 4 quarters. The position peaked at $456K in Q4 2023. 943 funds tracked by Wall St. Rank hold BIIB as of Q2 2024.

  • Garda Capital Partners reported no remaining Biogen position as of Q2 2024 after selling out during the quarter.
  • Garda Capital Partners sold 1,579 Biogen shares in Q2 2024, an estimated $340K.
  • Garda Capital Partners first reported a position in Biogen in Q1 2023 and held it in 4 quarters.
  • Garda Capital Partners's Biogen position peaked at $456K in Q4 2023.
  • 943 funds tracked by Wall St. Rank held Biogen as of Q2 2024.

Based on Garda Capital Partners's 13F filing for Q2 2024, filed 14 Aug 2024.